Real-World Impact of Low-Grade Toxicities to Adjuvant Pembrolizumab in Stage III Melanoma
Year: 2025
Type: article
Study design: Observational Study
Source: JCO Oncology Practice
DOI: 10.1200/op-24-01013
Authors: Nasreen Abdul Aziz, David Burke, Waleed Khalifa, Sharanniyan Ragavan, Ruth Board, Olabode Oladipo
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4408937730